Terms: = Leukemia AND LMO2, RBTN2, 4005, ENSG00000135363, P25791, TTG2, RBTNL1, RHOM2 AND Diagnosis
17 results:
1. Diagnostic utility of lmo2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
[TBL] [Abstract] [Full Text] [Related]
2. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract] [Full Text] [Related]
4. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.
Kunder CA; Roncador G; Advani RH; Gualco G; Bacchi CE; Sabile JM; Lossos IS; Nie K; Tibshirani RJ; Green MR; Alizadeh AA; Natkunam Y
Am J Clin Pathol; 2017 Nov; 148(6):465-476. PubMed ID: 29140403
[TBL] [Abstract] [Full Text] [Related]
5. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
6. lmo2 Is a Specific Marker of T-Lymphoblastic leukemia/Lymphoma.
Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
[TBL] [Abstract] [Full Text] [Related]
7. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
[TBL] [Abstract] [Full Text] [Related]
8. The utility of IgM, CD21, HGAL and lmo2 in the diagnosis of pediatric follicular lymphoma.
Karnik T; Ozawa MG; Lefterova M; Luna-Fineman S; Alvarez E; Link M; Zehnder JL; Arber DA; Ohgami RS
Hum Pathol; 2015 Apr; 46(4):629-33. PubMed ID: 25701230
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and lmo2 in Hematolymphoid Neoplasms.
Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
[TBL] [Abstract] [Full Text] [Related]
10. Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML.
Silva AG; Maschietto M; Vidal DO; Peliçario LM; Velloso ED; Lopes LF; Krepischi AC; Rosenberg C
Med Oncol; 2013 Dec; 30(4):734. PubMed ID: 24085545
[TBL] [Abstract] [Full Text] [Related]
11. HOX-mediated lmo2 expression in embryonic mesoderm is recapitulated in acute leukaemias.
Calero-Nieto FJ; Joshi A; Bonadies N; Kinston S; Chan WI; Gudgin E; Pridans C; Landry JR; Kikuchi J; Huntly BJ; Gottgens B
Oncogene; 2013 Nov; 32(48):5471-80. PubMed ID: 23708655
[TBL] [Abstract] [Full Text] [Related]
12. Detection of LIM domain only 2 (lmo2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
[TBL] [Abstract] [Full Text] [Related]
13. Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.
Alizadeh AA; Bohen SP; Lossos C; Martinez-Climent JA; Ramos JC; Cubedo-Gil E; Harrington WJ; Lossos IS
Leuk Lymphoma; 2010 Jul; 51(7):1200-16. PubMed ID: 20370541
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of microRNA expression characterize stages of human B-cell differentiation.
Zhang J; Jima DD; Jacobs C; Fischer R; Gottwein E; Huang G; Lugar PL; Lagoo AS; Rizzieri DA; Friedman DR; Weinberg JB; Lipsky PE; Dave SS
Blood; 2009 May; 113(19):4586-94. PubMed ID: 19202128
[TBL] [Abstract] [Full Text] [Related]
15. Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
Fischer S; Mann G; Konrad M; Metzler M; Ebetsberger G; Jones N; Nadel B; Bodamer O; Haas OA; Schmitt K; Panzer-Grümayer ER
Blood; 2007 Oct; 110(8):3036-8. PubMed ID: 17557895
[TBL] [Abstract] [Full Text] [Related]
16. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.
Lones MA; Heerema NA; Le Beau MM; Sposto R; Perkins SL; Kadin ME; Kjeldsberg CR; Meadows A; Siegel S; Buckley J; Abromowitch M; Kersey J; Bergeron S; Cairo MS; Sanger WG
Cancer Genet Cytogenet; 2007 Jan; 172(1):1-11. PubMed ID: 17175373
[TBL] [Abstract] [Full Text] [Related]
17. Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
Fizzotti M; Chen EY; Link MP; Carroll AJ; Foroni L; Rabbitts TH; Crist WM; Clark SS
Leukemia; 1994 Jul; 8(7):1124-30. PubMed ID: 8035604
[TBL] [Abstract] [Full Text] [Related]
